Prevention of Staphylococcus aureus biofilm formation and reduction in established biofilm density using a combination of phage K and modified derivatives

Letters in Applied Microbiology

Volumn 54, Issue 4, 2012, Pages 286-291

  Kelly, D ^a   Mcauliffe, O ^b   Ross, R P ^b   Coffey, A ^a  

^a Munster Technological University   (Ireland)

^b TEAGASC FOOD RESEARCH CENTRE   (Ireland)

Author keywords

Bacteriophage; Biocontrol; Biofilm; Cocktail; Modification; Staphylococcus aureus

Indexed keywords

BACTERIA; BACTERIOPHAGES;

% REDUCTIONS; BIOFILM BIOMASS; BIOFILM DENSITY; BIOFILM FORMATION; COCKTAIL; MICROTITRE PLATE; MODIFICATION; PHAGE COCKTAIL; STAPHYLOCOCCUS AUREUS; TIME-PERIODS;

BIOFILMS;

ANTIBIOTIC RESISTANCE; BACTERIOPHAGE; BACTERIUM; BIOCONTROL AGENT; BIOFILM; BIOLUMINESCENCE; BIOMASS; INFECTIVITY;

ARTICLE; BACTERIAL STRAIN; BACTERIOPHAGE; BIOFILM; BIOLUMINESCENCE; BIOMASS; CLINICAL EVALUATION; CONTROLLED STUDY; DENSITY; INCUBATION TEMPERATURE; INCUBATION TIME; MICROTITER PLATE ASSAY; NONHUMAN; REDUCTION KINETICS; STAPHYLOCOCCUS AUREUS; TIME;

STAPHYLOCOCCUS AUREUS;

EID: 84858276830     PISSN: 02668254     EISSN: 1472765X     Source Type: Journal    
DOI: 10.1111/j.1472-765X.2012.03205.x     Document Type: Article

References (39)

1. Azeredo, J. and Sutherland, I.W. (2008) The use of phages for the removal of infectious biofilms. Curr Pharm Biotechnol 9, 261-266.
2. Cerca, N., Martins, S., Cerca, F., Jefferson, K.K., Pier, G.B., Oliveira, R. and Azeredo, J. (2005) Comparative assessment of antibiotic susceptibility of coagulase-negative staphylococci in biofilm versus planktonic culture as assessed by bacterial enumeration or rapid XTT colorimetry. J Antimicrob Chemother 56, 331-336.
3. Cerca, N., Oliveira, R. and Azeredo, J. (2007) Susceptibility of Staphylococcus epidermidis planktonic cells and biofilms to the lytic action of Staphylococcus bacteriophage K. Lett Appl Microbiol 45, 313-317.
4. Curtin, J.J. and Donlan, R.M. (2006) Using bacteriophages to reduce formation of catheter-associated biofilms by Staphylococcus epidermidis. Antimicrob Agents Chemother 50, 1268-1275.
5. Donlan, R.M. (2009) Preventing biofilms of clinically relevant organisms using bacteriophage. Trends Microbiol 17, 66-72.
6. Donlan, R.M. and Costerton, J.W. (2002) Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15, 167-193.
7. Eftekhar, F. and Speert, D.P. (2009) Biofilm formation by persistent and non-persistent isolates of Staphylococcus epidermidis from a neonatal intensive care unit. J Hosp Infect 71, 112-116.
8. Fu, W., Forster, T., Mayer, O., Curtin, J.J., Lehman, S.M. and Donlan, R.M. (2010) Bacteriophage cocktail for the prevention of biofilm formation by Pseudomonas aeruginosa on catheters in an in vitro model system. Antimicrob Agents Chemother 54, 397-404.
9. Gill, J.J., Sabour, P.M., Leslie, K.E. and Griffiths, M.W. (2006) Bovine whey proteins inhibit the interaction of Staphylococcus aureus and bacteriophage K. J Appl Microbiol 101, 377-386.
10. Gorski, A., Miedzybrodzki, R., Borysowski, J., Weber-Dabrowska, B., Lobocka, M., Fortuna, W., Zimecki, M. et al. (2009) Bacteriophage therapy for the treatment of infections. Curr Opin Investig Drugs 10, 766-774.
11. Gupta, R. and Prasad, Y. (2011) Efficacy of polyvalent bacteriophage P-27/HP to control multidrug resistant Staphylococcus aureus associated with human infections. Curr Microbiol 62, 255-260.
12. Hell, E., Giske, C.G., Nelson, A., Romling, U. and Marchini, G. (2010) Human cathelicidin peptide LL37 inhibits both attachment capability and biofilm formation of Staphylococcus epidermidis. Lett Appl Microbiol 50, 211-215.
13. Hoiby, N., Biarnsholt, T., Givskoy, M., Molin, S. and Ciofu, O. (2010) Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents 35, 322-332.
14. Hughes, K.A, Sutherland, I.W. and Jones, M.V. (1998) Biofilm susceptibility to bacteriophage attack: the role of phaye-borne polysaccharide depolymerase. Microbiology 144, 3039-3047.
15. Jones, S.M., Morgan, M., Humphrey, T.J. and Lappin-Scott, H. (2001) Effect of vancomycin and rifampicin on methicillin-resistant Staphylococcus aureus biofilms. Lancet 357, 40-41.
16. Kadurugamuwa, J.L, Sin, L., Albert, E., Yu, J., Francis, K., DeBoer, M., Rubin, M., Bellinger-Kawahara, C. et al. (2003a) Direct continuous method for monitoring biofilm infection in a mouse model. Infect Immun 71, 882-890.
17. Kadurugamuwa, J.L, Sin, L.V., Yu, J., Francis, K.P., Kimura, R., Purchio, T. and Contaq, P.R. (2003b) Rapid direct method for monitoring antibiotics in a mouse model of bacterial biofilm infection. Antimicrob Agents Chemother 47, 3130-3137.
18. Kadurugamuwa, J.L., Sin, L.V., Yu, J., Francis, K.P., Purchio, T.F. and Contaq, P.R. (2004) Noninvasive optical imaging method to evaluate postantibiotic effects on biofilm infection in vivo. Antimicrob Agents Chemother 48, 2283-2287.
19. Kelly, D., McAuliffe, O., Ross, R.P., O'Mahony, J. and Coffey, A. (2011) Development of a broad-host-range phage cocktail for biocontrol. Bioeng Bugs 2, 1-7.
20. Keren, I., Shah, D., Spoering, A., Kaldalu, N. and Lewis, K. (2004) Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J Bacteriol 186, 8172-8180.
21. Kutter, E. and Sulakvelidze, A. (2005) Bacteriophage therapy in humans. In Bacteriophages; Biology and Applications ed. Kutter, E. and Sulakvelidze, A. pp. 393-394. Boca Raton, FL: CRC Press.
22. Lacqua, A., Wanner, O., Colangelo, T., Martinotti, M.G. and Landini, P. (2006) Emergence of biofilm-forming subpopulations upon exposure of Escherichia coli to environmental bacteriophages. Appl Environ Microbiol 72, 956-959.
23. O'Flaherty, S., Coffey, A., Edwards, R., Meaney, W., Fitzgerald, G.F. and Ross, R.P. (2004) Genome of staphylococcal phage K: a new lineage of Myoviridae infecting gram-positive bacteria with a low G+C content. J Bacteriol 186, 2862-2871.
24. O'Flaherty, S., Ross, R.P., Meany, W., Fitzgerald, G.F., Elbreki, M.F. and Coffey, A. (2005a) Potential of the polyvalent anti-Staphylococcus bacteriophage K for control of antibiotic-resistant staphylococci from hospitals. Appl Environ Microbiol 71, 1836-1842.
25. O'Flaherty, S., Ross, R.P., Flynn, J., Meaney, W.J., Fitzgerald, G.F. and Coffey, A. (2005b) Isolation and characterization of two anti-staphylococcal bacteriophages specific for pathogenic Staphylococcus aureus associated with bovine infections. Lett Appl Microbiol 41, 482-486.
26. O'Flaherty, S., Ross, R.P. and Coffey, A. (2009) Bacteriophage and their lysins for elimination of infectious bacteria. FEMS Microbiol Rev 33, 801-819.
27. Oliveira, M., Bexiga, R., Nunes, S.F., Carneiro, C., Cavaco, L.M., Bernardo, F. and Vilela, C.L. (2006) Biofilm-forming ability profiling of Staphylococcus aureus and Staphylococcus epidermidis mastitis isolates. Vet Microbiol 118, 133-140.
28. Otto, M. (2008) Staphylococcal biofilms. Curr Top Microbiol Immunol 322, 207-228.
29. Schroeder, K., Jularic, M., Horsburgh, S.M., Hirschhausen, N., Neumann, C., Bertling, A., Schulte, A., Foster, S. et al. (2009) Molecular characterization of a novel Staphylococcus aureus surface protein (SasC) involved in cell aggregation and biofilm accumulation. PLoS ONE 4, e7567.
30. Sharma-Kuinkel, B.K., Mann, E.E., Ahn, J.S., Kuechenmeister, L.J., Dunman, P.M. and Bayles, K.W. (2009) The Staphylococcus aureus LytSR two-component regulatory system affects biofilm formation. J Bacteriol 191, 4767-4775.
31. Sillankorva, S., Oliveira, R., Vieira, M., Suthereland, I.W. and Azeredo, J. (2004) Bacteriophage f-S1 infection of Pseudomonas fluorescens planktonic cells versus biofilms. Biofouling 20, 133-138.
32. Sjöström, J.E., Löfdahl, S. and Philipson, L. (1978) Biological characteristics of a type I restriction-modification system in Staphylococcus aureus. J Bacteriol 133, 1144-1149.
33. Sutherland, I.W., Hughes, K.A., Skillman, L.C. and Tait, K. (2004) The interaction of phage and biofilms. FEMS Microbiol Lett 232, 1-6.
34. Tock, MR. and Dryden, D.T. (2005) The biology of restriction and anti-restriction. Curr Opin Microbiol 8, 466-472.
35. Tu Quoc, P.H., Genevaux, P., Pajunen, M., Savilahti, H., Georgopoulos, C., Schrenzel, J. and Kelley, W.L. (2007) Isolation and characterization of biofilm formation-defective mutants of Staphylococcus aureus. Infect Immun 75, 1079-1088.
36. Vasudevan, P., Nair, M.K., Annamalai, T. and Venkitanarayanan, K.S. (2003) Phenotypic and genotypic characterization of bovine mastitis isolates of Staphylococcus aureus for biofilm formation. Vet Microbiol 92, 179-185.
37. Verma, V., Harjai, K. and Chhibber, S. (2009) Restricting ciprofloxacin-induced resistant variant formation in biofilm of Klebsiella pneumonia B5055 by complementary bacteriophage treatment. J Antimicrob Chemother 64, 1212-1218.
38. Wu, J.A., Kusuma, C., Mond, J.J. and Kokai-Kun, J.F. (2003) Lysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfaces. Antimicrob Agents Chemother 47, 3407-3414.
39. Ziebuhr, W. (2001) Staphylococcus aureus and Staphylococcus epidermidis: emerging pathogens in nosocomial infections. Contrib Microbiol 8, 102-107.